Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02079701 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits
A Phase 4 study, sponsored by Naval Health Research Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 152,723
- Enrollment target
NCT02079701: Completed Phase 4 study, sponsored by Naval Health Research Center.
NCT02079701 is a Phase 4 study that has completed, run by Naval Health Research Center. The registered enrollment target is 152,723 participants, above the 502-participant average among 9,235 other Phase 4 trials with a reported enrollment target (30323% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02079701, a Phase 4 study, has completed, sponsored by Naval Health Research Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 152,723 participants
- Enrollment target
Study Summary
The primary objective is to determine the clinical benefit of employing the 23-valent pneumococcal vaccine among US military trainees. Secondary objectives include: * determining the etiology of clinical pneumonia among U.S. military trainees; * comparing the serotype distribution of S. pneumoniae (Sp) isolates recovered from vaccinated and nonvaccinated trainees diagnosed with pneumonia; and * comparing days lost from training due to pneumonia or acute respiratory disease for vaccinated and nonvaccinated subjects.
Primary Outcome
During the active surveillance period while participants are still in recruit training(variable time frame depending on which Service), study participants with suspect pneumonia were identified by the attending physician. Study staff followed up on the results of chest xray to identify all radiographically-confirmed pneumonia cases.
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL 23-valent pneumococcal vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152,723 participants |
| Start Date | 2000-10 |
| Est. Completion | 2007-06 |
| Phase | Phase 4 |
What the finished NCT02079701 record still lists
NCT02079701 is an interventional study that assigns participants to a tested intervention. Its 152,723 participants enrollment target places it among the larger protocols in the corpus, above the 502-participant average among 9,235 other Phase 4 trials with a reported enrollment target (30323% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02079701 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02079701 about?
NCT02079701 is a clinical study titled "Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits". The primary objective is to determine the clinical benefit of employing the 23-valent pneumococcal vaccine among US military trainees. Secondary objectives include: * determining the etiology of clinical pneumonia among U.S. military trainees; * comparing the serotype distribution of S. pneumoniae ...
What is the current status of trial NCT02079701?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 152,723 participants. The study started on 2000-10. Estimated completion is 2007-06.
What interventions are being tested in trial NCT02079701?
The interventions under investigation include: Placebo (BIOLOGICAL), 23-valent pneumococcal vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT02079701?
This trial is sponsored by Naval Health Research Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02079701's enrollment target sits among peer trials
152,723 4th of 2000 higher than 1,997 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia